The Industry’s changing approach to clinical data monitoring requires the tools and team structure to effectively plan and execute risk-based monitoring. Join Lynn King and Rob Woolson as they discuss multi-disciplinary approaches to implementing alternative monitoring plans and specialized tools for successfully executing risk-based monitoring.
Assistant Vice President, Operations
Rob Woolson, MS
- What Non-statisticians Need to Know about Statistics in Clinical Trials
- Targeted Product Development: Personalized Medicine versus Orphan Product Development
- PDUFA V: What you need to know about the upcoming Prescription Drug User Fee Act
- Stop the pain: Tips for increasing patient retention and decreasing missing data in analgesia clinical trials